Corchon S, Rodriguez-Blazquez C, Carvajal-Carrascal G, Fuentes-Ramirez A, Ruiz de Ocenda MI, Caparros N, Timonet-Andreu E, Navarta-Sanchez MV, Ambrosio L. International psychometric validation of the Living with Chronic Illness Scale in Spanish-speaking patients with chronic obstructive pulmonary disease.
BMJ Open 2021;
11:e039973. [PMID:
33712522 PMCID:
PMC7959234 DOI:
10.1136/bmjopen-2020-039973]
[Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/01/2020] [Revised: 07/30/2020] [Accepted: 10/07/2020] [Indexed: 12/30/2022] Open
Abstract
OBJECTIVES
To validate the Living with Chronic Illness (LW-CI) Scale in patients with chronic obstructive pulmonary disease (COPD).
DESIGN
Observational, cross-sectional validation study with retest. Acceptability, reliability, precision and construct validity were tested.
SETTING
The study took place in primary and secondary specialised units of public and private hospitals of Spain and Colombia.
PARTICIPANTS
The study included 612 patients with COPD assessed from May 2018 to May 2019. A consecutive cases sampling was done. Inclusion criteria included: (A) patients with a diagnosis of COPD; (B) native Spanish speaking; (C) able to read and understand questionnaires; and (D) able to provide informed consent. Exclusion criteria included: (A) cognitive deterioration and (B) pharmacological effect or disorder that could disrupt the assessment.
RESULTS
The LW-CI-COPD presented satisfactory data quality, with no missing data or floor/ceiling effects, showing high internal consistency for all the domains (Cronbach's alpha for the total score 0.92). Test-retest reliability was satisfactory (intraclass correlation coefficient=0.92). The LW-CI-COPD correlated 0.52-0.64 with quality of life and social support measures. The scale demonstrated satisfactory known-groups validity, yielding significantly different scores in patients grouped according to COPD severity levels.
CONCLUSIONS
This has been the first validation study of the LW-CI-COPD. It is a feasible, reliable, valid and precise self-reported scale to measure living with COPD in the Spanish-speaking population. Therefore, it could be recommended for research and clinical practice to measure this concept and evaluate the impact of centred-care interdisciplinary interventions based on the patients' perspective, focused on providing holistic and comprehensive care to patients with COPD.
Collapse